Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 104,923 | 112,447 | 306,239 | 507,734 | 274,348 |
| Marketable Securities | 216,137 | 278,344 | 119,543 | 3,212 | 28,239 |
| Receivables | 79,069 | 56,950 | 50,599 | 29,413 | 8,646 |
| Inventories | 8,087 | 28,683 | 27,533 | 15,791 | 7,039 |
| TOTAL | $421,968 | $495,966 | $516,500 | $566,136 | $323,800 |
| Non-Current Assets | |||||
| PPE Net | 7,777 | 7,910 | 8,617 | 8,714 | 7,113 |
| Investments And Advances | 20,323 | 0 | 18,077 | 6,829 | 0 |
| Other Non-Current Assets | 40,352 | 13,084 | 6,806 | 6,472 | 3,802 |
| TOTAL | $68,452 | $20,994 | $33,500 | $22,015 | $10,915 |
| Total Assets | $490,420 | $516,960 | $550,000 | $588,151 | $334,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 32,676 | 23,565 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 11,644 | 20,893 | 14,356 | 27,808 | 40,383 |
| Accrued Expenses | 113,292 | 102,882 | 87,565 | 72,670 | 33,942 |
| TOTAL | $160,384 | $149,988 | $105,514 | $103,718 | $105,654 |
| Non-Current Liabilities | |||||
| Long Term Debt | 795,922 | 811,265 | 733,279 | 585,457 | 244,452 |
| Deferred Revenues | N/A | N/A | 1,224 | 1,421 | 150 |
| Other Non-Current Liabilities | 7,924 | 8,390 | 4,027 | 0 | 0 |
| TOTAL | $805,970 | $822,500 | $739,083 | $591,419 | $248,323 |
| Total Liabilities | $966,354 | $972,488 | $844,597 | $695,137 | $353,977 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 208,960 | 206,150 | 188,451 | 184,662 | 177,183 |
| Common Shares | 2,085 | 2,058 | 1,879 | 1,843 | 1,769 |
| Retained earnings | -1,770,040 | -1,681,159 | -1,454,620 | -1,207,504 | -1,023,442 |
| Other shareholders' equity | 921 | 1,337 | 26 | 177 | 3 |
| TOTAL | $-475,934 | $-455,528 | $-294,597 | $-106,986 | $-19,262 |
| Total Liabilities And Equity | $490,420 | $516,960 | $550,000 | $588,151 | $334,715 |